Coronavirus disease-2019 (COVID-19) pandemic has emerged as a public health emergency and has led to economic, occupational, and social disruption. Along with physical illness, it is also associated with disruption of mental health. In this case series, we have presented six different case reports of persons with COVID-19 illness, who presented to or were referred to the psychiatric assessment. These include panic disorder, mania, depressive episode, acute psychosis, delirium, and organic catatonia.
Coronavirus disease-2019 (COVID-2019). Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/coronavirus/2019-ncov/index.html [Accessed May 30, 2021].
Coronavirus disease (COVID-19) outbreak. World Health Organization. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [Accessed May 30, 2020].
Coronavirus disease (COVID-19) outbreak. World Health Organization. Available from: https://covid19.who.int/emergencies/diseases/dashboard/novel-coronavirus-2019 [Accessed May 30, 2020].
Alimohamadi Y, Sepandi M, Taghdir M, et al. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. Prev Med Hyg 2020;61(3):E304–E312. DOI: 10.15167/2421-4248/jpmh2020.61.3.1530.
Pereira-Sanchez V, Adiukwu F, El Hayek S, et al. COVID19 effect on mental health: patients and workforce. Lancet Psychiatry 2020;7(6):e29–e30. DOI: 10.1016/S2215-0366(20)30153-X.
Taquet M, Luciano S, Geddes JR, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2020;8(2):P130. DOI: 10.1016/s2215-0366(20)30462-4.
Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors, Brain Behav Immun 2020;89:594–600. DOI: 10.1016/j.bbi.2020.07.037.
Yoshimura R, Okamoto N, Konishi Y, et al. Panic disorder induced by the coronavirus disease pandemic in a patient with organic mood disorder successfully treated with vortioxetine. Case Rep Psychiatry 2020;2020. 3 p. Article ID 8870014. DOI: 10.1155/2020/8870014.
Frohman EM, Villemarette-Pittman NR, Melamed E, et al. Part I. SARS-CoV-2 triggered ‘PANIC’ attack in severe COVID-19. J Neurol Sci 2020;415:116936. DOI: 10.1016/j.jns.2020.116936.
Benros ME, Waltoft BL, Nordentoft M, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 2013;70(8):812–820. DOI: 10.1001/jamapsychiatry.2013.1111.
Reus GZ, Fries GR, Stertz L, et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience 2015;300:141–154. DOI: 10.1016/j.neuroscience.2015.05.018.
Lu S, Wei N, Jiang J, et al. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder. J Affect Disord 2020;277:337–340. DOI: 10.1016/j.jad.2020.08.031.
Ettman CK, Abdalla SM, Cohen GH, et al. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open 2020;3(9):e2019686. DOI: 10.1001/jamanetworkopen.2020.19686.
Deng J, Zhou F, Hou W, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis. Ann NY Acad Sci 2021;1486(1):90–111. DOI: 10.1111/nyas.14506.
Ferrando SJ, Klepacz L, Lynch S, et al. COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics 2020;61(5):551–555. DOI: 10.1016/j.psym.2020.05.012.
Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun 2020;88:945–946. DOI: 10.1016/j.bbi.2020.04.017.
Steardo L, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) 2020;229(3):e13473. DOI: 10.1111/apha.13473.
Global COVID-19 clinical platform NOVEL CORONAVIRUS (COVID-19)–rapid version. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-ncov-crf.pdf?sfvrsn=84766e69 [Accessed May 28, 2021].
D’Adamo H, Yoshikawa T, Ouslander JG. Coronavirus disease 2019 in geriatrics and long-term care: the ABCDs of COVID19. J Am Geriatr Soc 2020;68(5):912–917. DOI: 10.1111/jgs.16445.
McNeil JB, Hughes CG, Girard T, et al. Plasma biomarkers of inflammation, coagulation, and brain injury as predictors of delirium duration in older hospitalized patients. PLoS One 2029;14(12):e0226412. DOI: 10.1371/journal.pone.0226412.
LaHue SC, James TC, Newman JC, et al. Collaborative delirium prevention in the age of COVID-19. J Am Geriatr Soc 2020;68(5):947–949. DOI: 10.1111/jgs.16480.
Kennedy M, Helfand BKI, Gou RY, et al. Delirium in older patients with COVID-19 presenting to the emergency department. JAMA Netw Open 2020;3(11):e2029540. DOI: 10.1001/jamanetworkopen.2020.29540.
Oh ES, Fong TG, Hshieh TT, et al. Delirium in older persons: advances in diagnosis and treatment. Journal of the American Medical Association 2017;318(12):1161–1174. DOI: 10.1001/jama.2017.12067.
Rogers JP, Pollak TA, Blackman G, et al. Catatonia and the immune system: a review. Lancet Psychiatry 2019;6(7):620–630. DOI: 10.1016/S2215-0366(19)30190-7.
Wilson JE, Carlson R, Duggan MC. Delirium and catatonia in critically ill patients: the delirium and catatonia prospective cohort investigation. Crit Care Med 2017;45(11):1837–1844. DOI: 10.1097/CCM.0000000000002642.
Zain SM, Muthukanagaraj P, Rahman N. Excited catatonia–a delayed neuropsychiatric complication of COVID-19 infection. Cureus 2021;13(3):e13891. DOI: 10.7759/cureus.13891.